Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Recursion Pharmaceuticals, Inc./ 144

SEC Filing · 144

Recursion Pharmaceuticals, Inc.

RXRXNASDAQEQUITYCurrent

SEC Filing

Filed Aug 4, 2026Accepted Aug 4, 2026, 1:37 PM EDTCIK 1601830Accession 0001959173-26-005593
View company →Permanent SEC source ↗
Share

Company context

Current securities

RXRXNASDAQ · EQUITY · Current

Recent company filings

  1. Entry into a Material Definitive AgreementSep 21, 2026
  2. 144 filingSep 1, 2026
  3. 10-Q filingAug 5, 2026
  4. Results of Operations and Financial Condition · Regulation FD DisclosureAug 5, 2026
  5. SCHEDULE 13G filingJul 31, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗